21,31 %The overall COVID-19 PCR-positivity rate was 21.31% among 291 participants.
CamerounCOVID-19observé November 2020 to July 2021publié 2023VirusesOpenAlexdocument de 12 observationsDOI 10.3390/v15020407
Palier Gold : evidences validées mécaniquement, avec leur source primaire.
47 evidences · page 2 / 2
21,31 %The overall COVID-19 PCR-positivity rate was 21.31% among 291 participants.
CamerounCOVID-19observé November 2020 to July 2021publié 2023VirusesOpenAlexdocument de 12 observationsDOI 10.3390/v15020407
81,1 %On day 3, 77 out of 95 participants (81.1%) on hydroxychloroquine-azithromycin were asymptomatic.
CamerounCOVID-19publié 2023Cureuseurope_pmcdocument de 7 observations
80,4 %On day 3, 74 out of 92 participants (80.4%) on doxycycline were asymptomatic.
CamerounCOVID-19publié 2023Cureuseurope_pmcdocument de 7 observations
279,55 nmol/LThe mean baseline serum cortisol in the series of 80 COVID-19 positive patients was 279.55 nmol/L ± 128.68 (minimum 96.1332 nmol/L; maximum 665.0521 nmol/L).
CamerounCOVID-19publié 2020Baseline Serum Total Cortisol During the Primary Corona Virus Infection in the Beginning oeurope_pmcdocument de 12 observationsDOI 10.21203/rs.3.rs-78801/v1
97,9 %On day 10, 93 out of 95 participants (97.9%) on hydroxychloroquine-azithromycin were asymptomatic.
CamerounCOVID-19publié 2023Cureuseurope_pmcdocument de 7 observations
24,4 %Overall IgG seropositivity (IgM−/IgG+ and IgM+/IgG+) was 24.4% among 291 participants.
CamerounCOVID-19observé November 2020 to July 2021publié 2023VirusesOpenAlexdocument de 12 observationsDOI 10.3390/v15020407
95,7 %At day 10, 88 out of 92 participants (95.7%) on doxycycline were asymptomatic.
CamerounCOVID-19publié 2021Doxycycline is a safe alternative to Hydroxychloroquine + Azithromycin to prevent clinicaleurope_pmcdocument de 8 observationsDOI 10.1101/2021.07.25.21260838
8 casesAmong the 80 COVID-19 positive patients, cardiovascular disease was present in 8 (10%).
CamerounCOVID-19 · maladies cardiovasculairespublié 2020Baseline Serum Total Cortisol During the Primary Corona Virus Infection in the Beginning oeurope_pmcdocument de 12 observationsDOI 10.21203/rs.3.rs-78801/v1
28,76 %Women had a PCR-positivity rate of 28.76% compared to 13.04% in men.
CamerounCOVID-19observé November 2020 to July 2021publié 2023VirusesOpenAlexdocument de 12 observationsDOI 10.3390/v15020407
73 %73% (n = 22) of participants did not attend their appointment because of fear of being infected by SARS-CoV-2 at hospital.
CamerounCOVID-19observé April 2020publié 2020Gerontology & geriatric medicineeurope_pmcdocument de 6 observations
65,2 %SARS-CoV-2 PCR was negative at day 10 in 60 out of 92 participants (65.2%) allocated to doxycycline.
CamerounCOVID-19publié 2021Doxycycline is a safe alternative to Hydroxychloroquine + Azithromycin to prevent clinicaleurope_pmcdocument de 8 observationsDOI 10.1101/2021.07.25.21260838
36 casesAmong the 80 COVID-19 positive patients, fever was reported in 36 (45%).
CamerounCOVID-19publié 2020Baseline Serum Total Cortisol During the Primary Corona Virus Infection in the Beginning oeurope_pmcdocument de 12 observationsDOI 10.21203/rs.3.rs-78801/v1
66,3 %SARS-CoV-2 PCR was negative at day 10 in 63 out of 95 participants (66.3%) allocated to hydroxychloroquine-azithromycin.
CamerounCOVID-19publié 2021Doxycycline is a safe alternative to Hydroxychloroquine + Azithromycin to prevent clinicaleurope_pmcdocument de 8 observationsDOI 10.1101/2021.07.25.21260838
81,1 %At day 3, 77 out of 95 participants (81.1%) on hydroxychloroquine-azithromycin were asymptomatic.
CamerounCOVID-19publié 2021Doxycycline is a safe alternative to Hydroxychloroquine + Azithromycin to prevent clinicaleurope_pmcdocument de 8 observationsDOI 10.1101/2021.07.25.21260838
44 casesAmong the 80 COVID-19 positive patients, asthenia was reported in 44 (55%).
CamerounCOVID-19publié 2020Baseline Serum Total Cortisol During the Primary Corona Virus Infection in the Beginning oeurope_pmcdocument de 12 observationsDOI 10.21203/rs.3.rs-78801/v1
7,22 %Among 194 participants with IgM−/IgG−, 7.22% had positive PCR.
CamerounCOVID-19observé November 2020 to July 2021publié 2023VirusesOpenAlexdocument de 12 observationsDOI 10.3390/v15020407
80 patientsThe study included 80 COVID-19 positive patients, predominantly males (45, or 56.3% of the sample), with a mean age of 43 ± 13 years.
CamerounCOVID-19publié 2020Baseline Serum Total Cortisol During the Primary Corona Virus Infection in the Beginning oeurope_pmcdocument de 12 observationsDOI 10.21203/rs.3.rs-78801/v1
66,3 %On day 10, 63 out of 95 participants (66.3%) assigned to hydroxychloroquine-azithromycin had a negative SARS-CoV-2 PCR test.
CamerounCOVID-19publié 2023Cureuseurope_pmcdocument de 7 observations
None of the participants were admitted for worsening of the disease after treatment initiation.
CamerounCOVID-19publié 2021Doxycycline is a safe alternative to Hydroxychloroquine + Azithromycin to prevent clinicaleurope_pmcdocument de 8 observationsDOI 10.1101/2021.07.25.21260838
17,65 %Among 34 participants with COVID-19 IgM+/IgG+, 17.65% had negative PCR and 82.35% had positive PCR.
CamerounCOVID-19observé November 2020 to July 2021publié 2023VirusesOpenAlexdocument de 12 observationsDOI 10.3390/v15020407
13,04 %Men had a PCR-positivity rate of 13.04%.
CamerounCOVID-19observé November 2020 to July 2021publié 2023VirusesOpenAlexdocument de 12 observationsDOI 10.3390/v15020407
26,92 %Among 26 participants with COVID-19 IgM+/IgG−, 26.92% had negative PCR and 73.08% had positive PCR.
CamerounCOVID-19observé November 2020 to July 2021publié 2023VirusesOpenAlexdocument de 12 observationsDOI 10.3390/v15020407
Chaque ligne mène à son document source. Le nombre indiqué est celui des observations VALIDÉES qu'il porte, jamais celui des observations extraites : les deux diffèrent sur la plupart des documents. L'extrait exact du texte source n'est pas publié, par contrainte de droit d'auteur.